featured
2021 Top Story in Dermatology: Tofacitinib for Facial Hair Alopecia Areata
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Kerkemeyer KLS, Sinclair RD, Bhoyrul B. Topical Tofacitinib for the Treatment of Alopecia Areata Affecting Facial Hair. Br J Dermatol. 2021;185(3):677-679.
- Craiglow BG. Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes. JAAD Case Rep. 2018;4(10):988-989.
- Liu L, Craiglow B, King B. Tofacitinib 2% ointment, a topical Janus kinase inhibitor for the treatment of alopecia areata: a pilot study of 10 patients. J Am Acad Dermatol. 2018;78(2):403-404.
- Ferreira SB, Ferreira RB, Scheinberg MA. Topical tofacitinib in treatment of alopecia areata. einstein (São Paulo). 2020;18:eAI5452.
- Bayart, CB, Deniro KL, L Brichta, et al. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata. J Am Acad Dermatol. 2017;77(1): 167-170.
Disclosure statements are available on the authors' profiles: